Literature DB >> 27853643

Peritumoral stromal neutrophils are essential for c-Met-elicited metastasis in human hepatocellular carcinoma.

Min He1, Anping Peng1, Xian-Zhang Huang1, Dai-Chao Shi2, Jun-Cheng Wang2, Qiyi Zhao3, Haibiao Lin1, Dong-Ming Kuang2, Pei-Feng Ke1, Xiang-Ming Lao2.   

Abstract

Inflammation is a component of tumor progression mechanisms. Neutrophils are a common inflammatory infiltrate in many tumors, but their regulation and functions in neoplasia are not understood. Here, we showed, in detailed studies of c-Met molecule in 225 untreated patients with hepatocellular carcinoma (HCC), that high infiltration of neutrophils in HCC tissues determined malignant cell c-Met-associated clinical outcome of patients. High infiltration of neutrophils in HCCs determined malignant cell c-Met-associated clinical outcome of patients. Neutrophils were enriched predominantly in invading tumor edge of HCCs; the accumulated neutrophils were the major source of c-Met ligand HGF in HCCs. Exposure to HCC environments resulted in neutrophil activation and the following HGF production. Inhibiting the activities of Erk1/2, p38, and NF-κB, but not the phosphorylation of AKT or JNK, successfully attenuated the neutrophil HGF production induced by HCC environments. Further investigation revealed that GM-CSF was an important determinant in malignant cell-elicited neutrophil HGF production in vitro and in vivo. Moreover, we demonstrated that tumor neutrophils, via HGF/c-Met interaction, actively enhanced the metastasis of malignant cells in vitro and in vivo. These data provide direct evidence supporting the critical role of neutrophils in human tumor progression and reveal a fine-tuned collaborative action between cancer cells and immune cells in tumor milieu, which reroutes the immune activation into a tumor-promoting direction.

Entities:  

Keywords:  HCC; c-Met; hepatocyte growth factor; metastasis; tumor neutrophils

Year:  2016        PMID: 27853643      PMCID: PMC5087290          DOI: 10.1080/2162402X.2016.1219828

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  47 in total

Review 1.  Neutrophils and immunity: challenges and opportunities.

Authors:  Carl Nathan
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

2.  MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta.

Authors:  Min He; Zhenqun Xu; Tong Ding; Dong-Ming Kuang; Limin Zheng
Journal:  Cell Mol Immunol       Date:  2009-10       Impact factor: 11.530

3.  PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression.

Authors:  Xiao Xiao; Xiang-Ming Lao; Min-Min Chen; Rui-Xian Liu; Yuan Wei; Fang-Zhu Ouyang; Dong-Ping Chen; Xiao-Yu Zhao; Qiyi Zhao; Xue-Feng Li; Chuan-Lu Liu; Limin Zheng; Dong-Ming Kuang
Journal:  Cancer Discov       Date:  2016-02-29       Impact factor: 39.397

4.  c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma.

Authors:  Hanning You; Wei Ding; Hien Dang; Yixing Jiang; C Bart Rountree
Journal:  Hepatology       Date:  2011-07-19       Impact factor: 17.425

5.  Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.

Authors:  Asaf Spiegel; Mary W Brooks; Samin Houshyar; Ferenc Reinhardt; Michele Ardolino; Evelyn Fessler; Michelle B Chen; Jordan A Krall; Jasmine DeCock; Ioannis K Zervantonakis; Alexandre Iannello; Yoshiko Iwamoto; Virna Cortez-Retamozo; Roger D Kamm; Mikael J Pittet; David H Raulet; Robert A Weinberg
Journal:  Cancer Discov       Date:  2016-04-12       Impact factor: 39.397

6.  Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients.

Authors:  Dong-Ming Kuang; Chen Peng; Qiyi Zhao; Yan Wu; Ling-Yan Zhu; Jianen Wang; Xiao-Yu Yin; Lian Li; Limin Zheng
Journal:  J Immunol       Date:  2010-06-25       Impact factor: 5.422

7.  Lysophosphatidylcholine increases neutrophil bactericidal activity by enhancement of azurophil granule-phagosome fusion via glycine.GlyR alpha 2/TRPM2/p38 MAPK signaling.

Authors:  Chang-Won Hong; Taek-Keun Kim; Hwa-Yong Ham; Ju-Suk Nam; Yong Ho Kim; Haifeng Zheng; Bo Pang; Tae-Kwon Min; Jun-Sub Jung; Si-Nae Lee; Hyun-Jeong Cho; Ee-Jin Kim; In-Hwan Hong; Tae-Cheon Kang; Jongho Lee; Seog Bae Oh; Sung Jun Jung; Sung Joon Kim; Dong-Keun Song
Journal:  J Immunol       Date:  2010-03-17       Impact factor: 5.422

8.  The yin-yang of tumor-associated neutrophils.

Authors:  Alberto Mantovani
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

9.  A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.

Authors:  Shicheng Su; Qiang Liu; Jingqi Chen; Jianing Chen; Fei Chen; Chonghua He; Di Huang; Wei Wu; Ling Lin; Wei Huang; Jin Zhang; Xiuying Cui; Fang Zheng; Haiyan Li; Herui Yao; Fengxi Su; Erwei Song
Journal:  Cancer Cell       Date:  2014-05-12       Impact factor: 31.743

10.  MET is required for the recruitment of anti-tumoural neutrophils.

Authors:  Veronica Finisguerra; Giusy Di Conza; Mario Di Matteo; Jens Serneels; Sandra Costa; A A Roger Thompson; Els Wauters; Sarah Walmsley; Hans Prenen; Zvi Granot; Andrea Casazza; Massimiliano Mazzone
Journal:  Nature       Date:  2015-05-18       Impact factor: 49.962

View more
  23 in total

Review 1.  Trial Watch: Adoptively transferred cells for anticancer immunotherapy.

Authors:  Carole Fournier; François Martin; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi; Lionel Apetoh
Journal:  Oncoimmunology       Date:  2017-08-11       Impact factor: 8.110

Review 2.  The Tumor Microenvironment Innately Modulates Cancer Progression.

Authors:  Dominique C Hinshaw; Lalita A Shevde
Journal:  Cancer Res       Date:  2019-07-26       Impact factor: 12.701

Review 3.  Neutrophils as potential therapeutic targets in hepatocellular carcinoma.

Authors:  Daniel Geh; Jack Leslie; Rob Rumney; Helen L Reeves; Thomas G Bird; Derek A Mann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-01-12       Impact factor: 46.802

4.  Identification of an Innate Immune-Related Prognostic Signature in Early-Stage Lung Squamous Cell Carcinoma.

Authors:  Liang Li; Xue Yu; Guanqiang Ma; Zhiqi Ji; Shihao Bao; Xiaopeng He; Liang Song; Yang Yu; Mo Shi; Xiangyan Liu
Journal:  Int J Gen Med       Date:  2021-11-30

Review 5.  Neutrophils in cancer-unresolved questions.

Authors:  Melissa S F Ng; Leonard Tan; Quanbo Wang; Charles R Mackay; Lai Guan Ng
Journal:  Sci China Life Sci       Date:  2021-02-24       Impact factor: 6.038

Review 6.  Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment.

Authors:  Ze-Long Liu; Jing-Hua Liu; Daniel Staiculescu; Jiang Chen
Journal:  Ther Adv Med Oncol       Date:  2021-05-24       Impact factor: 8.168

7.  Electrospun Polydioxanone Loaded With Chloroquine Modulates Template-Induced NET Release and Inflammatory Responses From Human Neutrophils.

Authors:  Allison E Fetz; Shannon E Wallace; Gary L Bowlin
Journal:  Front Bioeng Biotechnol       Date:  2021-04-27

8.  Type of Necrosis Influences Prognosis in Hepatocellular Carcinoma After the First Transarterial Chemoembolization.

Authors:  Zhi-Juan Wu; Yin-Fa Xie; Xu Chang; Lin Zhang; Hui-Yong Wu; Ji-Bing Liu; Jian-Xin Zhang; Peng Sun
Journal:  Med Sci Monit       Date:  2021-05-10

Review 9.  Two Faces of Neutrophils in Liver Disease Development and Progression.

Authors:  Yeonhee Cho; Gyongyi Szabo
Journal:  Hepatology       Date:  2021-06-18       Impact factor: 17.298

10.  Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF.

Authors:  Takanori Kitamura; Yu Kato; Demi Brownlie; Daniel Y H Soong; Gaël Sugano; Nicolle Kippen; Jiufeng Li; Dahlia Doughty-Shenton; Neil Carragher; Jeffrey W Pollard
Journal:  Cancer Immunol Res       Date:  2019-10-15       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.